Anchored Immunotherapy as a Strategy for Targeting Cytokine Retention in the Tumor Microenvironment to Promote Tumor Regression Without Systemic Toxicity
Time: 3:30 pm
day: Day Two
Details:
• How Anchored immunotherapy is a novel drug delivery strategy that promotes local cytokine retention of and limits systemic diffusion
• How Anchored immunotherapy can increase the therapeutic window for immunooncology agents such as IL-12, to promote local effector anti-tumor T cell responses
• Combination therapy with anchored drugs can further drive therapeutic responses without adding systemic toxicity with immune checkpoint blockade, chemotherapy, and radiation therapy
